Neuroprotective and Antioxidant Effects of Neuroglutam in Cerebral Ischemia

Verfasser / Beitragende:
[I. Tyurenkov, E. Volotova, D. Kurkin, N. Mazina, D. Bakulin, I. Logvinov, T. Antipova]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/3(2015-07-01), 365-367
Format:
Artikel (online)
ID: 605535566
LEADER caa a22 4500
001 605535566
003 CHVBK
005 20210128100848.0
007 cr unu---uuuuu
008 210128e20150701xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2964-z  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2964-z 
245 0 0 |a Neuroprotective and Antioxidant Effects of Neuroglutam in Cerebral Ischemia  |h [Elektronische Daten]  |c [I. Tyurenkov, E. Volotova, D. Kurkin, N. Mazina, D. Bakulin, I. Logvinov, T. Antipova] 
520 3 |a We studied in vitro and in vivo neuroprotective and antioxidant properties of neuroglutam, a new glutamic acid derivative. In experiments on immortalized mouse hippocampal cell line HT22, neuroglutam exhibited a neuroprotective effect in the model of oxidative stress after its introduction, both before and after H2O2. In vivo study on animals treated with neuroglutam against the background of cerebral ischemia modeled by irreversible occlusion of the common carotid arteries showed that plasma level of TBA-active products was signifi cantly lower and activities of cell antioxidant enzymes (superoxide dismutase and catalase) were higher than in control animals receiving saline under the same conditions. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a neuroprotective properties  |2 nationallicence 
690 7 |a antioxidant system  |2 nationallicence 
690 7 |a neuroglutam  |2 nationallicence 
700 1 |a Tyurenkov  |D I.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Volotova  |D E.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Kurkin  |D D.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Mazina  |D N.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Bakulin  |D D.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Logvinov  |D I.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
700 1 |a Antipova  |D T.  |u V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/3(2015-07-01), 365-367  |x 0007-4888  |q 159:3<365  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2964-z  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2964-z  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tyurenkov  |D I.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Volotova  |D E.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kurkin  |D D.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mazina  |D N.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bakulin  |D D.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Logvinov  |D I.  |u Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Antipova  |D T.  |u V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/3(2015-07-01), 365-367  |x 0007-4888  |q 159:3<365  |1 2015  |2 159  |o 10517